secwatch.observer — SEC 8-K summary
======================================

Issuer:     MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK:        0001157601
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001193125-23-169187
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Madrigal stockholders approve charter amendment for officer exculpation at annual meeting
--------------------------------------------------------------------------------

- All three Class I director nominees elected: Paul Friedman, Kenneth Bate, James Daly.
- Ratification of PwC as independent auditor for FY2023 approved (16,111,585 for, 12,542 against).
- Advisory vote on executive compensation passed with 93.56% of votes cast FOR.
- Amendment to certificate of incorporation to provide officer exculpation from breach of fiduciary duty of care approved and filed June 16, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157601/000119312523169187/0001193125-23-169187-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157601/000119312523169187/d521638d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-169187

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer